Navigation Links
Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL)
Date:6/1/2009

clinical evaluation. In addition to Trubion's current clinical stage product pipeline, the Company is also developing additional product candidates that build on its product development experience. More information is available in the investors section of Trubion's website: http://investors.trubion.com/index.cfm.

Forward-Looking Statements

Certain statements in this release may constitute "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934 and Section 27A of the Securities Act of 1933. These statements include, but are not limited to, those related to the Company's future clinical development programs and the timing thereof, the Company's future regulatory filings and the timing and outcome thereof. These statements are based on current expectations and assumptions regarding future events and business performance and involve certain risks and uncertainties that could cause actual results to differ materially. These risks include, but are not limited to, risks associated with the clinical advancement of TRU-016, the Company's Wyeth collaboration, including Wyeth's control over development timelines, the risks that the Company is unable to advance its clinical development programs and regulatory applications and action at the rate it expects, and such other risks as identified in the Company's quarterly report on Form 10-Q for the period ended March 31, 2009, and from time to time in other reports filed by Trubion with the U.S. Securities and Exchange Commission. These reports are available on the Investors page of the company's corporate website at http://www.trubion.com/. Trubion undertakes no duty to update any forward-looking statement
'/>"/>

SOURCE Trubion Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting
2. Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
3. Trubion Pharmaceuticals Announces Presentation of Positive TRU-015 and SBI-087 Data at the 2008 Annual European Congress of Rheumatology Meeting
4. Trubion Announces Presentation of Positive TRU-016 Data at ASCO
5. Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis
6. Trubion Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid Arthritis
7. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
8. Trubion Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkins Lymphoma
9. Trubion Pharmaceuticals Announces Presentation of Positive Data From Phase IIb and Re-treatment Studies With TRU-015 in Patients With Rheumatoid Arthritis
10. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... -- Luminex Corporation (NASDAQ: LMNX ) today announced financial ...  Financial and operating highlights for the quarter include the ... by 6 percent to $58.9 million, over the second ... assay revenue by 22 percent to $24.2 million over ... Increased Q2 2015 royalty revenue by 17 percent to ...
(Date:8/3/2015)... Aug. 3, 2015 Diplomat Pharmacy, Inc. (NYSE: ... results for the quarter ended June 30, 2015. All comparisons, ... 2014. Second Quarter 2015 Highlights include: ... or $266 million , Total prescriptions dispensed of 234,000, ... versus 5.5% , Adjusted EBITDA of $22.7 million, an ...
(Date:8/3/2015)... N.Y. , Aug. 3, 2015 ... Wilmot Cancer Institute to the OmniSeq SM ... Roswell Park Cancer Institute (RPCI) and announced it ... that support a physician-driven, collaborative approach to genomic ... outcomes.  Wilmot Cancer Institute is a rapidly expanding, ...
Breaking Medicine Technology:Luminex Corporation Reports Record 2nd Quarter 2015 Results 2Luminex Corporation Reports Record 2nd Quarter 2015 Results 3Luminex Corporation Reports Record 2nd Quarter 2015 Results 4Luminex Corporation Reports Record 2nd Quarter 2015 Results 5Luminex Corporation Reports Record 2nd Quarter 2015 Results 6Luminex Corporation Reports Record 2nd Quarter 2015 Results 7Luminex Corporation Reports Record 2nd Quarter 2015 Results 8Luminex Corporation Reports Record 2nd Quarter 2015 Results 9Luminex Corporation Reports Record 2nd Quarter 2015 Results 10Luminex Corporation Reports Record 2nd Quarter 2015 Results 11Luminex Corporation Reports Record 2nd Quarter 2015 Results 12Luminex Corporation Reports Record 2nd Quarter 2015 Results 13Luminex Corporation Reports Record 2nd Quarter 2015 Results 14Luminex Corporation Reports Record 2nd Quarter 2015 Results 15Luminex Corporation Reports Record 2nd Quarter 2015 Results 16Diplomat Announces 2nd Quarter 2015 Financial Results 2Diplomat Announces 2nd Quarter 2015 Financial Results 3Diplomat Announces 2nd Quarter 2015 Financial Results 4Diplomat Announces 2nd Quarter 2015 Financial Results 5Diplomat Announces 2nd Quarter 2015 Financial Results 6Diplomat Announces 2nd Quarter 2015 Financial Results 7Diplomat Announces 2nd Quarter 2015 Financial Results 8Diplomat Announces 2nd Quarter 2015 Financial Results 9Diplomat Announces 2nd Quarter 2015 Financial Results 10Diplomat Announces 2nd Quarter 2015 Financial Results 11Diplomat Announces 2nd Quarter 2015 Financial Results 12Diplomat Announces 2nd Quarter 2015 Financial Results 13Diplomat Announces 2nd Quarter 2015 Financial Results 14Diplomat Announces 2nd Quarter 2015 Financial Results 15Diplomat Announces 2nd Quarter 2015 Financial Results 16Diplomat Announces 2nd Quarter 2015 Financial Results 17Diplomat Announces 2nd Quarter 2015 Financial Results 18OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 2OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 3
... South Africa, Nov. 29, 2011   Leatt Corporation ... Leatt-Brace®, a neck brace system designed to help prevent ... helmeted sports, today announced the formation of an agreement ... in New Zealand. Whites Powersports has more ...
... a full-service pharmacy and ancillary medical benefits management ... a patent-pending revolutionary risk assessment tool designed to ... for potential abuse and misuse of prescription medications. ... and unique algorithms developed by the myMatrixx clinical ...
Cached Medicine Technology:Leatt Announces Distribution Agreement With Whites Powersports for New Zealand Market 2myMatrixx Launches myRisk Predictor™ a Patent-Pending Risk Assessment Tool 2
(Date:8/4/2015)... ... August 04, 2015 , ... Please join us for the 4th Annual ... at Oneida Shores Park in Brewerton, NY. , Doris Connor was a healthy, ... the young age of 59. Her family and friends have since become steadfast in ...
(Date:8/4/2015)... ... August 04, 2015 , ... IN AMERICA ... which spotlights treating depression. Depression affects millions of Americans every single year. To ... inform and enlighten viewers with the latest segment produced with the assistance of ...
(Date:8/4/2015)... ... August 04, 2015 , ... Following last month’s successful ... The Benefits of Cath Lab Accreditation in an Academic Setting, and The Importance of ... Setting , taped during the 2015 Society for Cardiovascular Angiography and Interventions (SCAI) ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... their partnership to make the Isabel Symptom Checker available to all users of ... a mechanism to check their symptoms in an easy, intuitive method, provides access ...
(Date:8/3/2015)... ... August 04, 2015 , ... While the pace of the economic recovery since the 2008 has ... on a growth trajectory for the last six years. Unemployment has dropped from a 2009 ... a 3.5 percent growth rate in 2014, the U.S. stock market is at an all ...
Breaking Medicine News(10 mins):Health News:4th Annual Doris A. Connor Memorial Event for Brain Aneurysm Awareness to be Held in Brewerton, NY with Proceeds Benefitting Renowned Brain Aneurysm Foundation 2Health News:4th Annual Doris A. Connor Memorial Event for Brain Aneurysm Awareness to be Held in Brewerton, NY with Proceeds Benefitting Renowned Brain Aneurysm Foundation 3Health News:Accreditation for Cardiovascular Excellence (ACE) Clients Explain Benefits of ACE Accreditation 2Health News:Accreditation for Cardiovascular Excellence (ACE) Clients Explain Benefits of ACE Accreditation 3Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 2Health News:Isabel Healthcare Partners with the Kansas Health Information Network, Inc. to Deploy Isabel Symptom Checker within the MyKSHealth eRecord Personal Health Record 3Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 2Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 3Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 4
... Africans are coming forward to seek counseling and undergo ... figures, the Department of Health has reported.// ... utilized the screening services since 2000, thanks to the ... status. In 2005/06, nearly 1.7-million people underwent the pre-HIV ...
... in North Dakota and South Dakota are coming ... for their mammograms without// ever leaving the reservation. ... traditional mobile mammography, in which a large truck ... Using digital mammography instead of films and adding ...
... Australia has decided to include Gardasil in the national immunization ... cervical cancer. The// immunization program is expected to cover high ... of 12 and 18 will benefit from this program. All ... be able to avail this facility through their GPs for ...
... six provinces to step up vigilance following an outbreak of ... ,South Korea Tuesday reported its second outbreak in ... culled. ,Heilongjiang, Jilin, Liaoning, Shandong, Jiangsu and Zhejiang ... ,The agriculture ministry said the outbreak poses a serious threat ...
... Chinese Taipei (Taiwan) in a qualifying match of the Asian ... to have chicken// pox. ,"Maldives team lost today's match ... a statement. ,"Five players of Maldives have ... we have to make sure players of other teams are ...
... inhaling hazardous chemicals dumped into a stream just outside ... , ,About 3,000 residents from five villages in ... to prevent them from inhaling the fumes, said Superintendent ... of chest pain, dizziness and nausea. ,Aquilates ...
Cached Medicine News:Health News:Telemedicine Improves Breast Screenings for Rural Indian Reservations 2Health News:Maldives Volleyball Team Members Affected by Chickenpox 2
The Invacare Pulse Oximeter provides fast, reliable SpO2 and pulse-rate measurements on any patient from infant to adult. It's designed for simple, accurate spot-checking and is a member of a full-li...
The miniSPO 2 T has the same advanced DOX digital technology as our multiple parameter vital signs monitors and lets you evaluate oxygen saturation and heart rate in a broad range of patients, from n...
The PalmSAT® 2500 series are small, yet versatile digital pulse oximeters for accurate assessment of blood oxygen saturation and pulse rate. Choose alarm or non-alarm versions for your portable ...
... The Avant® 4000 System with Bluetooth® ... connections while ensuring reliable and secure ... in a small package. The lightweight ... to a small tabletop display, improving ...
Medicine Products: